Doherty, NiamhCardwell, Chris RMurchie, PeterHill, ChristopherAzoulay, LaurentHicks, Blánaid2024-01-042024-01-042023-03-06Doherty, N, Cardwell, C R, Murchie, P, Hill, C, Azoulay, L & Hicks, B 2023, '5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia : A Population-Based Cohort Study', Cancer Epidemiology, Biomarkers and Prevention, vol. 32, no. 3, pp. 428-434. https://doi.org/10.1158/1055-9965.EPI-22-11091055-9965ORCID: /0000-0001-9968-5991/work/127817939https://hdl.handle.net/2164/22496Financial Support: Dr’s B Hicks and CR Cardwell received funding from Cancer Research UK Population Research Fellowship (grant reference 22185). The funder had no role in the study design, analysis, interpretation or writing of the manuscript7341694engSDG 3 - Good Health and Well-beingBenign prostatic hyperplasiakidney cancerbladder cancer5-alpha reductase inhibitorepidemiologyR MedicineCancer Research UK22185Supplementary DataRJournal article10.1158/1055-9965.EPI-22-1109323